Form 4: Cassava Sciences Director, Claude Nicaise, Granted Stock Options

Director Claude Nicaise of Cassava Sciences Inc. received 10,000 stock options on May 9, 2024, as part of the company's Non-employee Director Compensation Program.

Summary

• On May 9, 2024, Claude Nicaise, a director of Cassava Sciences Inc., was granted 10,000 stock options.
• These options were granted under the Non-employee Director Compensation Program, which was approved by stockholders on May 4, 2023.
• The exercise price of the options is $21.11.
• The options vest over a one-year period, at a rate of 1/12 per month, and expire on May 9, 2034.
• Following this transaction, Nicaise directly owns 10,000 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of stock options is a routine part of director compensation and aligns interests with shareholders. There are no indications of negative news or concerns.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company over the next year.

Industry Context

Stock option grants are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders and incentivizing them to increase company value.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary significantly across the biotechnology industry depending on company size, stage of development, and performance.
• Comparing Cassava Sciences' director compensation to companies like Biogen, Eli Lilly, or smaller biotech firms would provide a benchmark for assessing the competitiveness and appropriateness of the grant.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it aligns the director's interests with increasing shareholder value.
• The director is incentivized to contribute to the company's success over the vesting period.

Key Dates